Visit the euRIMS website for criteria, download the submission form, and take your chance to make an impact now!
The European Association of Neuroscience Nurses (EANN) Conference 2027 will take place in Spain. Details on dates and location are coming soon—stay tuned for updates and get ready to join neuroscience nursing professionals from across Europe!
Upcoming 2024 revisions to the McDonald criteria will integrate new MRI technologies and biomarkers, such as neurofilament light chain and the central vein sign, to enable earlier and more accurate MS diagnoses, including in individuals previously classified as having radiologically isolated syndrome.
Explore new findings reporting how vaccinations do not increase the risk of MS in children and adolescents and how urinary tract infections are the leading cause of hospital admissions for people with MS, underscoring the need for improved bladder care and outpatient management strategies.
Explore the latest research insights for MS nurses, covering key advancements in MS management. Highlights include the potential of high-dose vitamin D to delay early MS progression, the impact of disease-modifying treatments on slowing disability in RRMS, and findings from the MS-STAT2 trial on simvastatin’s limitations in SPMS. Stay informed with these evidence-based updates to enhance patient care.
Multiple sclerosis (MS) can significantly impact sexual health, with 40-80% of women and 50-90% of men with MS reporting sexual concerns. Challenges may arise from direct neurological effects, disease symptoms, or psychological and social factors.
Significant progress has advanced our understanding of NMOSD and MOGAD. This 30-minute microlearning covering key features, diagnostic criteria, and emerging therapies, enabling better differentiation from MS will be launch in January 2025.
Elisabeth Kasilingam, CEO of EMSP, addressed the MEP Interest Group on Brain Health and Neurological Conditions in the European Parliament, emphasizing the hidden challenges faced by individuals with neurological conditions and their caregivers.
The city of Prague will host the EMSP Annual Conference 2025 from May 16-17 at Hotel Don Giovanni. This year's theme, "Prevention in Multiple Sclerosis and Related Disorders: Uncovering Risk and Protective Factors," brings together experts to delve into innovative approaches to managing MS and related conditions.
Are you an early-career nurse under 40? Join the ECTRIMS Young MS HCP Committee to contribute to impactful MS initiatives and grow your professional network. Apply by 25 November!
Learn what generics and biosimlars are, the regulatory framework ensuring their quality and what specific expertise nurses need to employ to get their patients onboard to adopt and adhere to these therapies.
Hematopoietic stem cell transplantation (HSCT), Bruton's tyrosine kinase (BTK) inhibitors and chimeric antigen receptor (CAR) T-cell therapies are three potential future MS therapies currently under investigation. Read more about latest developments in this blogpost.
Discover a collection of educational tools designed to enhance MS nurses' understanding of biologics and biosimilars, from comprehensive presentations to quick-reference guides. Each tool is tailored to support nurses in delivering knowledgeable, patient-centered care.
Discover essential guidance on advancing care strategies for MS and neuroimmune diseases with Brain Health – Time Matters: A 2024 Update on MS, NMOSD, and MOGAD Care. This comprehensive report offers practical approaches for timely intervention, personalized treatment, and ongoing patient-centered support.
Gain insights into the evolving role of generics and biosimilars in multiple sclerosis treatment. This upcoming webinar will cover their efficacy, safety, and practical application in clinical settings, offering valuable knowledge for healthcare professionals.
MS nurses K-J Lazarus and Fiona d’Young share their experiences from ECTRIMS 2024, discussing their unique role in supporting people with multiple sclerosis in a conversation with Brett Drummond of MSTranslate.
Read how these topics empower self-management, the real-life experiences and a patient-centered approach to managing MS for improved outcomes.
Our Foundation Programme on MS nursing has international and national accreditation. It confirm the relevance and quality of our e-learning courses and ensures you, as a nurse, are recognised for the additional training on MS treatment and care.
In collaboration with IOMSN, MS Nurse PRO ensured insightful nursing sessions at ECTRIMS 2024.
+120 nurses learned about brain health and self-management & self-advocacy in two sessions.
Read more about MS Nurse PRO @ ECTRIMS here.
Intermittent catheterization is the preferred treatment for urinary retention, ensuring catheter users receive dignified, high-quality care across healthcare settings. Developed by global experts and endorsed by catheter users, the Principles aim to educate, foster patient-provider collaboration, and standardize care through evidence-based recommendations.
It is important for MS Nurses to have a good understanding of generics and biosimilars, including what they are and how they are approved by regulatory agencies, and to have confidence in discussing these with PwMS as they are likely to become an increasing part of clinical practice moving forward.
ECTRIMS offers to nurses a Professional Training Fellowship Programme designed to give you hands-on experience and advanced training in a mentored MS environment across Europe.
If you are looking to expand your expertise in MS - apply before 1 December 2024 !
Course 1 on Understanding MS and Course 2 on the Clinical Presentation of MS have been renewed!
Enroll to our Foundation Programme on MS Nursing available in the Catalogue to check it out!
Ready to turn your knowledge into impactful action? MS Nurse PRO and Birmingham University offer a unique 3-month work-based learning programme. Register your interest today and stay informed when enrollments open.
World MS Day on May 30th focused on early and accurate diagnosis. Despite progress, a report by MS Australia revealed an average 4-year delay from symptom onset to diagnosis, leading to irreversible damage and disability progression.
ChatGPT vs. neurologist: what do patient prefer? High efficacy treatment in paediatric-onset MS to significantly reduce disability progression. Updated guidance on cladribine for aggressive RRMS. PwMS with cognitive impairment tend to report a worse quality of life compared to PwMS without it.
The European Commission has approved a subcutaneous formulation of ocrelizumab to treat adults with MS and it is now available to people with relapsing forms of multiple sclerosis as well as primary progressive multiple sclerosis.
Despite effective vaccines, many older adults suffer from preventable diseases. At the 2023 AAFP Family Medicine Experience, experts Jeremy Szeto and Kristen Robillard shared strategies to optimize adult vaccinations and enhance doctor-patient communication.
Join Multiple Sclerosis Awareness Run during the Brussels Airport Half Marathon or 7K on November 3rd! Have fun and raise awareness and support for people affected with MS by participating in this event and help improve their lives.
Nurse burnout, prevalent in up to 68% of nurses, not only affects the well-being of nurses but also has significant negative impacts on patients and healthcare organizations. Read how to recognise the signs and how to avoid burning-out.